Skip to main content
Top

Cancer Microenvironment

Issue 1/2009

Content (7 Articles)

Open Access Original Paper

Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients

Frank M. Speetjens, Gerrit Jan Liefers, Cornelis J. Korbee, Wilma E. Mesker, Cornelis J.H. van de Velde, Ronald L. van Vlierberghe, Hans Morreau, Rob A. Tollenaar, Peter J.K. Kuppen

Open Access Original Paper

Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts

Andrea Sadlonova, Damon B. Bowe, Zdenek Novak, Shibani Mukherjee, Virginia E. Duncan, Grier P. Page, Andra R. Frost

Open Access Original Paper

Genotype-Dependent Tumor Regression in Marek’s Disease Mediated at the Level of Tumor Immunity

Shyamesh Kumar, Joram J. Buza, Shane C. Burgess

Open Access Original Paper

Stromal Myofibroblasts Accompany Modifications in the Epithelial Phenotype of Tongue Dysplastic and Malignant Lesions

Marilena Vered, Irit Allon, Amos Buchner, Dan Dayan

Open Access Original Paper

Regulated Expression of CCL21 in the Prostate Tumor Microenvironment Inhibits Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer

Nazita Yousefieh, Suzanne M. Hahto, Amber L. Stephens, Richard P. Ciavarra

Open Access Original Paper

The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β

Pawan Kaler, Bramara N. Godasi, Leonard Augenlicht, Lidija Klampfer

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine